CAPR · Capricor Therapeutics, Inc.
$19.50
+0.06 (+0.31%)
At close · Jul 20
Market Cap
$1.15B
Shares
57.91M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-14 | 2026-07-09 | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-26 | — | |
| 8-K | 2026-06-08 | 2026-06-04 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-10 | 2026-06-04 | |
| 10-K | 2026-03-17 | 2025-12-31 | |
| 8-K | 2026-03-12 | — | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2025-12-05 | — | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-12-03 | — | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-08-11 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-07-11 | — | |
| 8-K | 2025-05-27 | 2025-05-22 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-08 | 2025-05-22 | |
| 8-K | 2025-04-08 | — | |
| 10-K | 2025-03-26 | 2024-12-31 | |
| 8-K | 2025-03-19 | — | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-02 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-17 | 2024-10-16 | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-10-09 | — | |
| 8-K | 2024-09-24 | — | |
| 8-K | 2024-09-17 | 2024-09-16 | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 8-K | 2024-05-15 | 2024-05-14 | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-04-01 | 2024-05-14 | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-02-29 | — | |
| 8-K | 2024-01-11 | — | |
| 8-K | 2023-12-11 | — | |
| 8-K | 2023-11-14 | — | |
| 10-Q | 2023-11-14 | 2023-09-30 | |
| 8-K | 2023-09-29 | — |
Showing 1–50 of 116 filings